Related Experiment Videos
Porphyrins and hepatotoxicity
1Centers for Disease Control, Atlanta, Georgia 30333.
Annals of the New York Academy of Sciences
|January 1, 1987
Summary
Human porphyrias, like porphyria cutanea tarda, are rare metabolic disorders. This condition, often linked to liver enzyme deficiency or toxic exposure, affects porphyrin metabolism and can cause varied liver pathology.
Area of Science:
- Biochemistry
- Hepatology
- Genetics
Background:
- Human porphyrias are rare inherited disorders affecting porphyrin metabolism.
- Porphyria cutanea tarda (PCT) is a specific type that can arise spontaneously or due to external factors like drugs and alcohol.
- PCT is characterized by uroporphyrinogen decarboxylase deficiency in the liver, distinguishing it from acquired forms.
Purpose of the Study:
- To differentiate between the constitutional and acquired forms of porphyria cutanea tarda.
- To describe the spectrum of liver pathology associated with PCT.
- To highlight key biochemical and morphological features of PCT.
Main Methods:
- Review of clinical cases and biochemical analyses of patients with porphyria cutanea tarda.
- Histopathological examination of liver biopsies from affected individuals.
- Comparison of findings between constitutional and acquired PCT cases.
Main Results:
- Constitutional PCT is linked to liver uroporphyrinogen decarboxylase deficiency.
- Acquired PCT was notably observed in mass poisoning incidents (e.g., hexachlorobenzene in Turkey).
- Liver pathology in PCT ranges from minimal changes to severe alterations, often with increased iron and crystalline mitochondrial material.
Conclusions:
- PCT presents with diverse liver manifestations depending on the causative agent.
- Distinguishing between constitutional and acquired PCT is crucial for diagnosis and management.
- Increased hepatic iron and mitochondrial crystalline inclusions are common pathological findings in PCT.